1
|
Chen Y, Liu R, Chu Z, Le B, Zeng H, Zhang
X, Wu Q, Zhu G, Chen Y, Liu Y, et al: High glucose stimulates
proliferative capacity of liver cancer cells possibly via
O-GlcNAcylation-dependent transcriptional regulation of GJC1. J
Cell Physiol. 234:606–618. 2018. View Article : Google Scholar : PubMed/NCBI
|
2
|
Rodríguez-Hernández MA, González R, de la
Rosa AJ, Gallego P, Ordóñez R, Navarro-Villarán E, Contreras L,
Rodríguez-Arribas M, González-Gallego J, Álamo-Martínez JM, et al:
Molecular characterization of autophagic and apoptotic signaling
induced by sorafenib in liver cancer cells. J Cell Physiol.
234:692–708. 2018. View Article : Google Scholar : PubMed/NCBI
|
3
|
Wei KR, Yu X, Zheng RS, Peng XB, Zhang SW,
Ji MF, Liang ZH, Ou ZX and Chen WQ: Incidence and mortality of
liver cancer in China, 2010. Chin J Cancer. 33:388–394.
2014.PubMed/NCBI
|
4
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
5
|
Bruix J, Reig M and Sherman M:
Evidence-based diagnosis, staging, and treatment of patients with
hepatocellular carcinoma. Gastroenterology. 150:835–853. 2016.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Global Burden of Disease Cancer
Collaboration, ; Fitzmaurice C, Dicker D, Pain A, Hamavid H,
Moradi-Lakeh M, MacIntyre MF, Allen C, Hansen G, Woodbrook R, Wolfe
C, et al: The Global Burden of Cancer 2013. JAMA Oncol. 1:505–27.
2015. View Article : Google Scholar : PubMed/NCBI
|
7
|
Li W, Li DM, Chen K, Chen Z, Zong Y, Yin
H, Xu ZK, Zhu Y, Gong FR and Tao M: Development of a gene therapy
strategy to target hepatocellular carcinoma based inhibition of
protein phosphatase 2A using the α-fetoprotein promoter enhancer
and pgk promoter: An in vitro and in vivo study. BMC Cancer.
12:5472012. View Article : Google Scholar : PubMed/NCBI
|
8
|
Jiang H, Lin JJ, Su ZZ, Goldstein NI and
Fisher PB: Subtraction hybridization identifies a novel melanoma
differentiation associated gene, mda-7, modulated during human
melanoma differentiation, growth and progression. Oncogene.
11:2477–2486. 1995.PubMed/NCBI
|
9
|
Menezes ME, Bhoopathi P, Pradhan AK, Emdad
L, Das SK, Guo C, Wang XY, Sarkar D and Fisher PB: Role of
MDA-7/IL-24 a multifunction protein in human diseases. Adv Cancer
Res. 138:143–182. 2018. View Article : Google Scholar : PubMed/NCBI
|
10
|
Wang CJ, Xue XB, Yi JL, Chen K, Zheng JW,
Wang J, Zeng JP and Xu RH: Melanoma differentiation-associated
gene-7, MDA-7/IL-24, selectively induces growth suppression,
apoptosis in human hepatocellular carcinoma cell line HepG2 by
replication-incompetent adenovirus vector. World J Gastroenterol.
12:1774–1779. 2006. View Article : Google Scholar : PubMed/NCBI
|
11
|
Hassan M, Watari H, AbuAlmaaty A, Ohba Y
and Sakuragi N: Apoptosis and molecular targeting therapy in
cancer. BioMed Res Int. 2014:1508452014. View Article : Google Scholar : PubMed/NCBI
|
12
|
Thomas S, Quinn BA, Das SK, Dash R, Emdad
L, Dasgupta S, Wang XY, Dent P, Reed JC, Pellecchia M, et al:
Targeting the Bcl-2 family for cancer therapy. Expert Opin Ther
Targets. 17:61–75. 2013. View Article : Google Scholar : PubMed/NCBI
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Bhoopathi P, Lee N, Pradhan AK, Shen XN,
Das SK, Sarkar D, Emdad L and Fisher PB: mda-7/IL-24 induces cell
death in neuroblastoma through a novel mechanism involving AIF and
ATM. Cancer Res. 76:3572–3582. 2016. View Article : Google Scholar : PubMed/NCBI
|
15
|
Lin C, Liu H, Li L, Zhu Q, Liu H, Ji Z,
Liao J, Lang J, Wu J and Fan J: MDA-7/IL-24 inhibits cell survival
by inducing apoptosis in nasopharyngeal carcinoma. Int J Clin Exp
Med. 7:4082–4090. 2014.PubMed/NCBI
|
16
|
Menezes ME, Shen XN, Das SK, Emdad L, Guo
C, Yuan F, Li YJ, Archer MC, Zacksenhaus E, Windle JJ, et al:
MDA-7/IL-24 functions as a tumor suppressor gene in vivo in
transgenic mouse models of breast cancer. Oncotarget.
6:36928–36942. 2015. View Article : Google Scholar : PubMed/NCBI
|
17
|
Park MA, Hamed HA, Mitchell C,
Cruickshanks N, Dash R, Allegood J, Dmitriev IP, Tye G, Ogretmen B,
Spiegel S, et al: A serotype 5/3 adenovirus expressing MDA-7/IL-24
infects renal carcinoma cells and promotes toxicity of agents that
increase ROS and ceramide levels. Mol Pharmacol. 79:368–380. 2011.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Wang X, Ye Z, Zhong J, Xiang J and Yang J:
Adenovirus-mediated IL-24 expression suppresses hepatocellular
carcinoma growth via induction of cell apoptosis and cycling arrest
and reduction of angiogenesis. Cancer Biother Radiopharm. 22:56–63.
2007. View Article : Google Scholar : PubMed/NCBI
|
19
|
Gupta P, Su ZZ, Lebedeva IV, Sarkar D,
Sauane M, Emdad L, Bachelor MA, Grant S, Curiel DT and Dent P:
mda-7/IL-24: Multifunctional cancer-specific apoptosis-inducing
cytokine. Pharmacol Ther. 111:596–628. 2006. View Article : Google Scholar : PubMed/NCBI
|
20
|
Dai G, Zheng D, Guo W, Yang J and Cheng
AY: Cinobufagin induces apoptosis in osteosarcoma cells via the
mitochondria-mediated apoptotic pathway. Cell Physiol Biochem.
46:1134–1147. 2018. View Article : Google Scholar : PubMed/NCBI
|
21
|
Ferrer PE, Frederick P, Gulbis JM, Dewson
G and Kluck RM: Translocation of a Bak C-terminus mutant from
cytosol to mitochondria to mediate cytochrome C release:
Implications for Bak and Bax apoptotic function. PLoS One.
7:e315102012. View Article : Google Scholar : PubMed/NCBI
|
22
|
Mondal S, Bhattacharya K, Mallick A,
Sangwan R and Mandal C: Bak compensated for Bax in p53-null cells
to release cytochrome c for the initiation of mitochondrial
signaling during Withanolide D-induced apoptosis. PLoS One.
7:e342772012. View Article : Google Scholar : PubMed/NCBI
|
23
|
Renault TT, Floros KV and Chipuk JE:
BAK/BAX activation and cytochrome c release assays using isolated
mitochondria. Methods. 61:146–155. 2013. View Article : Google Scholar : PubMed/NCBI
|